Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB Co-infected Patients (ANRS 12146 CARINEMO)
Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the use of Nevirapine in HIV patients
already treated against tuberculosis by Rifampicin is as efficient and as well tolerated as
Efavirenz.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
French National Agency for Research on AIDS and Viral Hepatitis